-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Oncology Institute, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2021 to Q1 2024.
- Oncology Institute, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $0.000.
- Oncology Institute, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was -$76K, a 71.1% increase from 2022.
- Oncology Institute, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was -$263K, a 78.8% increase from 2021.
- Oncology Institute, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was -$1.24M, a 7.59% increase from 2020.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)